My PCR
Create Account
Logo PCR
Mitral valve replacement and repair

Tendyne transcatheter mitral valve system in patients with severe mitral annular calcification: one-year outcomes from the SUMMIT Severe MAC cohort

Reported from TCT 2025

Luigi Biasco interviews Paul Sorajja about the SUMMIT MAC Pivotal Trial he presented at TCT 2025, in San Francisco.

This trial shows how Tendyne provides a safe and effective treatment for patients with severe mitral annular calcification and limited surgical options.

Latest news from TCT 2025

Authors

Luigi Biasco
Luigi Biasco
@BiascoDr

Interventional cardiologist / Cardiologist

OSPEDALE CIRIÈ - Ciriè, Italy

Paul Sorajja
Paul Sorajja

Interventional cardiologist / Cardiologist

Abbott Northwestern Hospital - Minneapolis, United States of America

Join the discussion

No comments yet!

Disclaimer

This case report does not reflect the opinion of PCR or PCRonline, nor does it engage their responsibility.

Related Content
Tricuspid, mitral and structural innovations Transcatheter mitral valve-in-valve in prior degenerated mitral valve: LIVE Educational Case... Best Clinical Cases of AICT-AsiaPCR 2025
Recommended for you
What’s new in the 2025 guidance on valvular heart disease - ESC Congress 2025 Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines PCR Tokyo Valves 2026: What's on the Programme?